ClinicalTrials.gov record
Completed Phase 1 Interventional

Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults

ClinicalTrials.gov ID: NCT01165359

Public ClinicalTrials.gov record NCT01165359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase 1b Study to Assess the Safety and Activity of the HCV Entry Inhibitor ITX 5061 in Treatment-Naive HCV Mono-Infected Adults

Study identification

NCT ID
NCT01165359
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
30 participants

Conditions and interventions

Conditions

Interventions

  • ITX 5061 Drug
  • Placebo ITX 5061 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Jan 31, 2012
Completion
Feb 29, 2012
Last update posted
Oct 31, 2021

2010 – 2012

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294-2050
UCLA CARE Center CRS Los Angeles California 90035
Ucsd, Avrc Crs San Diego California 92103
Ucsf Aids Crs San Francisco California 94110
Johns Hopkins Adult AIDS CRS Baltimore Maryland
Univ. of Rochester ACTG CRS Rochester New York 14642
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Univ. of Cincinnati CRS Cincinnati Ohio 45267-0405
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01165359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01165359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →